Your browser doesn't support javascript.
loading
Requirements for Meaningful Progress in the Therapy of Neuroendocrine Cancers.
Labadie, Brian W; Fojo, Antonio Tito.
Afiliación
  • Labadie BW; Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
  • Fojo AT; Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
JAMA Oncol ; 9(5): 606-608, 2023 05 01.
Article en En | MEDLINE | ID: mdl-36892851
This Viewpoint discusses the role of data interpretation and clinical trial design in improving therapy of neuroendocrine cancers.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tumores Neuroendocrinos / Carcinoma Neuroendocrino Límite: Humans Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tumores Neuroendocrinos / Carcinoma Neuroendocrino Límite: Humans Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article